ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
This medicinal product is subject to additional monitoring. This will allow quick identification of ... In order to improve the traceability of biological medicinal products, the name and the batch number . ... baseline, was similar to that seen in the general population. Reporting of suspected adverse reactions .
Download ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Information
Domain:
Source:
Link to this page:
Documents from same domain
Russia - Country Page - European Commission
ec.europa.euLast update: November 2017 1 Russia - Country Page 1. Available national programmes or funds that could provide support to Russian Horizon 2020 participants
Evaluation of Innovation Activities - European …
ec.europa.euJune 2012 Evaluation of Innovation Activities Guidance on methods and practices Evaluation of Innovation Activities Guidance on methods and practices
EN Horizon 2020 Work Programme 2018-2020
ec.europa.euHorizon 2020 - Work Programme 2018-2020 Health, demographic change and wellbeing Part 8 - Page 3 of 124 SC1-BHC-19-2019: Implementation research for maternal and child health..... 41
H2020 Programme - ec.europa.eu
ec.europa.eu5 Your policy should also: reflect the current state of consortium agreements on data management be consistent with exploitation and Intellectual Property Rights (IPR)
International Accounting Standard 39 Financial …
ec.europa.euEC staff consolidated version as of 18 February 2011 FOR INFORMATION PURPOSES ONLY 1 International Accounting Standard 39 Financial …
International Financial Reporting Standard 1
ec.europa.euEC staff consolidated version as of 21/06/2012, ²² EN – EU IFRS 1 FOR INFORMATION PURPOSES ONLY International Financial Reporting Standard 1
International Financial Reporting Standard 3 …
ec.europa.euEC staff consolidated version as of 18 February 2011 FOR INFORMATION PURPOSES ONLY 1 International Financial Reporting Standard 3 Business Combinations
Literature review Teachers’ core ... - ec.europa.eu
ec.europa.eu© European Commission 1 EUROPEAN COMMISSION Directorate-General for Education and Culture Lifelong learning: policies and …
WP243 ANNEX - FREQUENTLY ASKED QUESTIONS …
ec.europa.euWP243 ANNEX - FREQUENTLY ASKED QUESTIONS The objective of this annex is to answer, in a simplified and easy-to-read format, some of the key questions that organisations may have regarding the new requirements under the GDPR to appoint a
Teachers’ continuing professional development
ec.europa.eu© European Commission 2 Literature review Quality in Teachers’ continuing professional developmenti 1. Teacher Professional Development: the …
Related documents
Isosteresin Medicinal Chemistry Group Meeting Christos ...
www.scripps.edubiological activity. Thornber(1979): Groups or molecules which have chemical and physical similarities producing broadly similar biological effects. Parameters affected with bioisostericreplacements Size, conformation, inductive and mesomericeffects, polarizability, H-bond formation capacity, pK a, solubility, hydrophobicity, reactivity, stability.
Recommendations for the evaluation of animal cell cultures ...
www.who.intHistorically, the major concerns regarding the safety of biological medicinal products manufactured in animal cells have been related to the possible presence of microbial contaminants and, in some cases, to the properties and components of the cells themselves such as DNA and proteins.
Transport route profiling qualification
www.who.intoverall size and weight should be similar to the container(s) used for the product(s) which are being monitored – this will ensure that the same handling practices are used. Warm life (test): The empty passive container is stabilized at +18.0°C and loaded with warm water-packs, which have been stabilized at the same temperature for a minimum of
Guideline on similar biological medicinal products ...
www.ema.europa.euGuideline on similar biological medicinal products containing biotechnology -derived proteins as active substance: non-clinical and clinical issues (EMEA/CHMP/BMWP/42832/05 Rev.1) lays down the non-clinical and clinical requirements for a …
PRINCIPLES OF MEDICINAL CHEMISTRY
www.ysmubooks.ambetween chemical structure and biological activity, theories of drug action, and mechanism of ... Definition Medicinal chemistry, also called therapeutic chemistry, pharmaceutical chemistry, pharmacochemistry, and chemical pharmacy is that field of pharmaceutical sciences which applies the ... more active, and c) with similar or different ...
Implementation Working Group ICH Q11 Guideline ...
database.ich.orgmeaning that the proposed starting material should be structurally similar to the drug substance. However, as stated in ICH Q11, this general principle is intended to help distinguish starting materials from reagents, catalysts, solvents, or other raw materials.
Guideline on similar biological medicinal products ...
www.ema.europa.euThe Guideline on similar biological medicinal products containing biotechnology -derived proteins as active substance: quality issues lays down the quality requirements for a biological medicinal product claiming to be similar to another one already marketed.